Form 4: Moleculin Biotech Executive Reports Stock Transaction
Insider Transaction (Form 4)
Donald H Picker, Chief Science Officer of Moleculin Biotech, Inc., reported multiple transactions in common stock on November 4, 2026.
Summary
- Option exercise/conversion: acquired 17 Common Stock on November 4, 2026; holds 8,722 after (Direct).
- Tax/exercise-price withholding: disposed of 4 Common Stock at $8.46 ($34) on November 4, 2026; holds 8,718 after (Direct).
- Option exercise/conversion: disposed of 18 Restricted Stock Units on November 4, 2026; holds 39,474 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Donald H Picker — Officer (Chief Science Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-04 | Option exercise/conversion | Common Stock | 17 | — | — | 8,722 |
| 2026-11-04 | Tax/exercise-price withholding | Common Stock | 4 | $8 | $34 | 8,718 |
| 2026-11-04 | Option exercise/conversion | Restricted Stock Units | 18 | — | — | 39,474 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-04 | Option exercise/conversion (17 shares) |
| 2026-11-04 | Tax/exercise-price withholding (4 shares) |
| 2026-11-04 | Option exercise/conversion (18 shares) |
Keywords
insider transaction, Form 4, MBRX, Moleculin Biotech, Inc., neutral, Donald H Picker
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.